{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:13:01Z","timestamp":1789985581278,"version":"4.0.1"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1002\/pds.3937","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T06:34:32Z","timestamp":1450679672000},"page":"196-203","source":"Crossref","is-referenced-by-count":72,"title":["Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry"],"prefix":"10.1002","volume":"25","author":[{"given":"Janouk","family":"Diphoorn","sequence":"first","affiliation":[{"name":"Department of Dermatology; Papa Giovanni XXIII Hospital; Bergamo Italy"},{"name":"Centro Studi GISED; Bergamo Italy"},{"name":"Faculty of Health, Medicine and Life Sciences; Maastricht University; Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cazzaniga","sequence":"additional","affiliation":[{"name":"Centro Studi GISED; Bergamo Italy"},{"name":"Department of Dermatology; Inselspital University Hospital; Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Gamba","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Papa Giovanni XXIII Hospital; Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Allergology and Immunology Unit; Niguarda Ca' Granda Hospital; Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Citterio","sequence":"additional","affiliation":[{"name":"Burn\/Intensive Care Department; Niguarda Ca' Granda Hospital; Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma Lisa","family":"Rivolta","sequence":"additional","affiliation":[{"name":"Regional Center of Pharmacovigilance; Lombardy Region; Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Danilo","family":"Vighi","sequence":"additional","affiliation":[{"name":"Quality, Privacy and Clinical Risk Unit; Niguarda Ca' Granda Hospital; Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Naldi","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Papa Giovanni XXIII Hospital; Bergamo Italy"},{"name":"Centro Studi GISED; Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The REACT-Lombardia study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"10.1002\/pds.3937-BIB0001|pds3937-cit-0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"10.1002\/pds.3937-BIB0002|pds3937-cit-0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/pds.3937-BIB0003|pds3937-cit-0003","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3937-BIB0004|pds3937-cit-0004","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1001\/jamadrematol.2014.4844","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis. Ear, nose, and throat description at acute stage and after remission","volume":"151","author":"Bequignon","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1002\/pds.3937-BIB0005|pds3937-cit-0005","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3937-BIB0006|pds3937-cit-0006","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1002\/pds.3937-BIB0007|pds3937-cit-0007","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/9781118357606.ch68","volume-title":"Evidence Based Dermatology, 3","author":"Roujeau","year":"2014"},{"key":"10.1002\/pds.3937-BIB0008|pds3937-cit-0008","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","article-title":"Open Trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"163","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1002\/pds.3937-BIB0009|pds3937-cit-0009","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1002\/pds.3937-BIB0010|pds3937-cit-0010","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1701\/1626.17670","article-title":"Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia","volume":"105","author":"Gamba","year":"2014","journal-title":"Recenti Prog Med"},{"key":"10.1002\/pds.3937-BIB0011|pds3937-cit-0011","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Steven-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/pds.3937-BIB0012|pds3937-cit-0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1002\/pds.3937-BIB0013|pds3937-cit-0013","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exudativum multiforme majus, Stevens-Johnson syndrome and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1002\/pds.3937-BIB0014|pds3937-cit-0014","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/ddg.12747","article-title":"Severe drug-induced skin reactions: clinical features, diagnosis, etiology and therapy","volume":"13","author":"Paulman","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"10.1002\/pds.3937-BIB0015|pds3937-cit-0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archderm.1990.01670320127028","article-title":"Incidence of toxic epidermal necrolysis in Italy","volume":"126","author":"Naldi","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1002\/pds.3937-BIB0016|pds3937-cit-0016","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.burns.2013.03.011","article-title":"27\u2009years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risks for causative agents","volume":"39","author":"Weinand","year":"2013","journal-title":"Burns"},{"key":"10.1002\/pds.3937-BIB0017|pds3937-cit-0017","first-page":"287","volume-title":"Dermatology","author":"French","year":"2008","edition":"2"},{"key":"10.1002\/pds.3937-BIB0018|pds3937-cit-0018","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1002\/pds.3937-BIB0019|pds3937-cit-0019","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2222.2011.03875.x","article-title":"Poor relevance of a lymphocyte proliferation assay in laminotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"42","author":"Tang","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1002\/pds.3937-BIB0020|pds3937-cit-0020","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study","volume":"353","author":"Rzany","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/pds.3937-BIB0021|pds3937-cit-0021","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1002\/pds.3937-BIB0022|pds3937-cit-0022","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1021\/tx5005248","article-title":"Systems pharmacological analysis of drugs inducing Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"28","author":"Hur","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1002\/pds.3937-BIB0023|pds3937-cit-0023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/pds.3937-BIB0024|pds3937-cit-0024","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions. A nationwide population-based study in Taiwan","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1002\/pds.3937-BIB0025|pds3937-cit-0025","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5415\/apallergy.2014.4.1.68","article-title":"Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen","volume":"4","author":"Kim","year":"2014","journal-title":"Asia Pac Allergy"},{"key":"10.1002\/pds.3937-BIB0026|pds3937-cit-0026","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/0378-6323.110749","article-title":"A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population","volume":"79","author":"Patel","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1002\/pds.3937-BIB0027|pds3937-cit-0027","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1542\/peds.2015-0278","article-title":"Outbreak of Mycoplasma pneumonia-associated Stevens-Johnson syndrome","volume":"136","author":"Olson","year":"2015","journal-title":"Pediatrics"},{"key":"10.1002\/pds.3937-BIB0028|pds3937-cit-0028","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/pde.12177","article-title":"Mycoplasma pneumoniae-induced recurrent Stevens-Johnson syndrome in children: a case report","volume":"30","author":"Campagna","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1002\/pds.3937-BIB0029|pds3937-cit-0029","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"key":"10.1002\/pds.3937-BIB0030|pds3937-cit-0030","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1002\/pds.3937-BIB0031|pds3937-cit-0031","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/BCR.0b013e31820aafbc","article-title":"Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study","volume":"32","author":"Sekula","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1002\/pds.3937-BIB0032|pds3937-cit-0032","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14052","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies","author":"Wu","year":"2015","journal-title":"Br J Dermatol"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3937","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3937","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pds.3937\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T07:12:50Z","timestamp":1718262770000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3937"}},"subtitle":["Incidence of SJS and TEN in northern Italy"],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3937","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}